Affiliation:
1. College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
2. Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing 210023, China
Abstract
There is a serious mixing of Piperis Herba and Piperis Kadsurae Caulis in various parts of China due to the similar traits of lianas, and there is a lack of systematic research on the compound and activity evaluation of the two. Likewise, the differences in compounds brought about by the distribution of origin also need to be investigated. In this study, high-resolution liquid–mass spectrometry (UPLC-Q-Zeno-TOF-MS/MS) was used to analyze samples of Piperis Herba from five origins and Piperis Kadsurae Caulis from five origins, with three batches collected from each origin. The compounds were identified based on precise molecular weights, secondary fragments, and an online database combined with node-to-node associations of the molecular network. The t-test was used to screen and analyze the differential compounds between the two. Finally, the preliminary evaluation of antioxidant activity of the two herbs was carried out using DPPH and ABTS free radical scavenging assays. The results showed that a total of 72 compounds were identified and deduced in the two Chinese medicines. These compounds included 54 amide alkaloids and 18 other compounds, such as flavonoid glycosides. The amide alkaloids among them were then classified, and the cleavage pathways in positive ion mode were summarized. Based on the p-value of the t-test, 32 differential compounds were screened out, and it was found that the compounds of Piperis Herba were richer and possessed a broader spectrum of antioxidant activity, thus realizing a multilevel distinction between Piperis Herba and Piperis Kadsurae Caulis. This study provides a preliminary reference for promoting standardization and comprehensive quality research of the resources of Piperis Herba using Piperis Kadsurae Caulis as a reference.
Funder
Science and Technology Project of Jiangsu Provincial Science and Technology Department
Reference31 articles.
1. Research progress of platelet activating factor(PAF) receptor antagonist;Li;Zhongguo Zhong Yao Za Zhi,2018
2. Research Progress on Analgesic Effect of Piper Genus Native to Yunnan Province;Zhou;Chin. J. Tradit. Chin. Med.,2022
3. Carsono, N., Tumilaar, S.G., Kurnia, D., Latipudin, D., and Satari, M.H. (2022). A Review of Bioactive Compounds and Antioxidant Activity Properties of Piper Species. Molecules, 27.
4. National Pharmacopoeia Committee (2020). Pharmacopoeia of the People’s Republic of China. Part I, Chemical Industry Press.
5. Chemical constituents and antibacterial activity from the stems and leaves of Piper wallichii;Nongmai;J. Asian Nat. Prod. Res.,2022